Seeking Alpha

KOOLANDTHEGANG's  Instablog

KOOLANDTHEGANG
Send Message
Long term stock investor.
View KOOLANDTHEGANG's Instablogs on:
  • Central Thesis for an Investment in Thermogenesis Corporation

    The market is completely snoozing on Thermogenesis Corp. (KOOL) -- but that's OK -- I continue to buy more.


    In my view, here are the primary investment considerations:

    (A) High Margins, Higher Margin Projections
    • illustrates pricing and market power and the extent to which KOOL products are integral to the cord blood/stem cell extraction process
    • suggests the company has already achieved "economies of scale" taking away much of the leverage a prospective acquirer might otherwise have

    (B) Cord Blood Becoming the "Go-To" Source for Adult Stem Cells and Adult Stem Cells Becoming More and More Indispensable
    • Not too long before every expecting mother will at least have the option to store its child's cord blood
    • Cord blood collection and stem cell extraction simply cannot exist without Kool's AXP and BioArchive

    (C) Has the Worldwide Distribution Network Befitting a Billion Dollar Company
    • How many sub-$50mm companies are selling their products on virtually every continent? Enough said.

    (D) Even Putting Aside AXP and BioArchive, Tremendous Growth Opportunities Abound
    • Res-Q
    • PRP
    • MXP
    • Adipose
    • Clinical Trials
    • Cardiac applications abound
    • New product extensions and new products that haven't even been announced

    (E) Last But Not Least: CLEAN BALANCE SHEET AND INSANELY CHEAP VALUATION
    • No debt
    • Verge of profitability
    • - < 2X price to book and price to sales

    It boggles my mind that this company is trading at a lower valuation than at any time in its 20 year history, and yet has the all the trappings of a future billion dollar company. I hope to be able to say one day that I was lucky enough to buy this stock before it becomes the CSCO or MSFT of the stem-cell industry.

    Disclosure: I am long KOOL.
    Tags: KOOL
    May 04 5:06 PM | Link | 4 Comments
Full index of posts »
Latest Followers

StockTalks

  • CENTRAL THESIS FOR AN INVESTMENT IN KOOL: CORD BLOOD AND ADULT STEM CELL INDUSTRY SIMPLY CANNOT CONTINUE TO EXIST WITHOUT KOOL'S PRODUCTS
    May 4, 2011
  • KOOL: Cord blood storage is fast becoming something offered as an option to all expecting mothers throughout the world
    May 4, 2011
  • KOOL: Every day, new usages for adult stem cells are being discovered or established; the potential uses are unknowable at this point
    May 4, 2011
More »

Latest Comments


Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.